AbbVie (ABBV) Receivables Refunds (2013 - 2015)

AbbVie (ABBV) has 3 years of Receivables Refunds data on file, last reported at $142.0 million in Q1 2015.

• Quarterly Receivables Refunds fell 84.89% year-over-year to $142.0 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $142.0 million (down 84.89% YoY) and the FY2014 annual result came in at $556.0 million, down 41.41% from the prior year.
• Receivables Refunds slipped to $142.0 million in Q1 2015 per ABBV's latest filing, from $556.0 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $949.0 million in Q4 2013 and bottomed at $127.0 million in Q2 2014.
• The 3-year median for Receivables Refunds is $479.5 million (2014), against an average of $519.5 million.
• The widest annual swing landed in 2014, when Receivables Refunds slumped 41.41%; it then slumped 84.89% in 2015.
• Tracing ABBV's Receivables Refunds over 3 years: stood at $949.0 million in 2013, then tumbled by 41.41% to $556.0 million in 2014, then tumbled by 74.46% to $142.0 million in 2015.
• Per Business Quant, the three latest ABBV Receivables Refunds figures stand at $142.0 million (Q1 2015), $556.0 million (Q4 2014), and $403.0 million (Q3 2014).

Peer Comparison